Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide (Wegovy) does produce meaningful weight loss in the absence of structured exercise — the STEP 1 clinical trial, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks in adults who combined the treatment with a reduced-calorie diet and lifestyle counselling, without mandating a specific exercise programme. That said, the decision of how much physical activity to include alongside Wegovy is worth thinking through carefully, because the evidence on what activity adds (and what it doesn't) shapes how most people get the best out of treatment. Wegovy is a prescription-only medicine; a clinician assesses whether it's appropriate for you before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question many people arrive with is a sensible one: if the medicine is suppressing appetite and changing how the body regulates energy, does it actually need exercise to work? Looking at the clinical evidence honestly, the answer is no, not as a prerequisite. The STEP 1 trial participants followed dietary guidance and received lifestyle counselling, but there was no requirement to hit a step count or attend a fitness class. Average weight loss of roughly 15% over 68 weeks is a substantial outcome, and it was achieved in a population that included people with limited mobility, joint problems and low baseline activity.
What the trials also show, consistently, is that adding regular activity on top of the medicine and the diet does improve results at the margins. A more active participant generally loses slightly more weight over the same period. But the gap is far smaller than many people expect, because the dominant driver of weight loss on semaglutide is the appetite effect, not calorie burn from movement. If you are currently unable to exercise (because of a joint condition, disability, fatigue or simply circumstance) that is not a reason to rule out treatment. You can read more about the range of typical Wegovy weight loss outcomes and what the data say about how results vary between individuals.
The practical implication is that exercise is worth doing for its own sake (for cardiovascular health, mood, bone density, blood pressure) but framing it as the key lever for the number on the scales tends to mislead people about why Wegovy works.
Here is where the exercise question gets more nuanced. When the body loses weight quickly (whether through food restriction, medicine, or both) it does not lose only fat. Some lean mass, including muscle, is lost alongside it. This is true of any significant calorie deficit, and semaglutide is no exception.
The concern is not just cosmetic. Muscle is metabolically active tissue; losing a meaningful proportion of it makes long-term weight maintenance harder. There is also a practical question about strength, energy and how you feel day-to-day during treatment. NHS England's guidance on weight-management injections highlights the importance of adequate protein intake and physical activity (particularly resistance-based movement) alongside these medicines for exactly this reason.
You do not need to start a formal programme before you begin Wegovy. Many people find their capacity for activity increases naturally as weight comes off and joints feel easier. Starting with walking, swimming or body-weight exercises at home is enough. The target is preserving what you have, not building an athlete's physique. A prescriber or dietitian can help you think through what is realistic for your situation. If you are curious about the early weeks of treatment, what weight loss looks like in the first month on Wegovy is covered separately.
There is a misconception worth letting go of gently: that people who lose weight on Wegovy without going to a gym are somehow doing it wrong, or that their results will be short-lived. The clinical picture does not support that narrative. What matters for sustained results is the quality of the eating pattern, the clinical support around dose titration, and consistent use of the medicine, not a specific exercise modality.
That said, 'without structured exercise' is different from 'completely sedentary'. Light daily movement (walking to the shops, taking the stairs, pottering in the garden) contributes to overall energy balance and, more importantly, to mood and motivation during treatment. These things matter for the longer arc of weight management even if they do not swing the scales dramatically week to week.
For people weighing up whether Wegovy is the right route, it helps to understand the full timeline. How long Wegovy takes to work explains the titration period and when most people begin to notice a change, which can take patience in the early weeks at lower doses. The dose escalation schedule is managed by your prescriber; the Wegovy overview page covers the licensed schedule and eligibility criteria if you want to check the basics first.
The right framework here is not 'do I exercise enough to deserve this medicine?' It is: given your health picture, your mobility, your lifestyle and your goals, what combination of treatment and activity is realistic and sustainable for you? That is a clinical question, and it is exactly what a prescriber is there to help you work through.
If you have a condition that limits exercise (osteoarthritis, a cardiovascular condition, chronic fatigue, or anything else) tell your prescriber. These factors are relevant to how treatment is managed, not reasons to be turned away. If you are wondering about the longer arc of how quickly results accumulate, the pace of weight loss on Wegovy and when you might first notice a change are both worth reading before you start.
Wegovy is a prescription-only medicine requiring clinical assessment. If you'd like to understand whether you're suitable, check your eligibility through a free consultation with one of our prescribers, reviewed the same day by a real clinician, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.